Mandatory Guidelines for Federal Workplace Drug Testing Programs

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Substance Abuse and Mental Health Services Administration AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Revised mandatory guidelines. SUMMARY: The Department of Health and Human Services (“HHS” or “Department”) is establishing standards for determining the validity of urine specimens collected under the Mandatory Guidelines for Federal Workplace Drug Testing Programs. These standards ensure that specimen validity testing (SVT) and reporting procedures are uniformly applied to all Federal agency urine specimens when a validity test is conducted. DATES: Effective Date: November 1, 2004. Comment Date: Submit comments on or before June 14, 2004. ADDRESSES: You may submit comments, identified by (insert docket number and/or RIN number), by any of the following methods: E-mail: wvogl@samhsa.gov . Include docket number and/or RIN number in the subject line of the message. Fax: 301-443-3031. Mail: 5600 Fishers Lane, Rockwall II, Suite 815, Rockville, Maryland 20857. Hand Delivery/Courier: 5515 Security Lane, Suite 815, Rockville, Maryland 20852. Instructions: All submissions received must include the agency name and docket number or Regulatory Information Number (RIN) for this rulemaking. All comments will be available for public review at 5515 Security Lane, Suite 815, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Walter F. Vogl, Ph.D., Division of Workplace Programs, CSAP…